Erin Cox, APRN
Nurse Practitioner · Leawood, KSNPI 1407213846
Payments from drug & device makers
Across 33 payments — averaging $45.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$871
- Smith+Nephew$85
- Melinta Therapeutics, LLC$72
- Stryker$55
- Argentum Medical$55
- Viiv Healthcare Company$52
- plus $297 from 13 others
What the payments were for
- Travel & lodging$81255%
- Food & beverage$67445%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 5 | $871 |
| Smith+Nephew | 2 | $85 |
| Melinta Therapeutics, LLC | 5 | $72 |
| Stryker | 2 | $55 |
| Argentum Medical | 1 | $55 |
| Viiv Healthcare Company | 2 | $52 |
| GSK | 2 | $45 |
| Ossur Americas, Inc. | 2 | $44 |
| Heron Therapeutics, Inc. | 2 | $35 |
| Edwards Lifesciences | 1 | $26 |
| Genentech USA, Inc. | 1 | $26 |
| Baudax Bio Inc. | 1 | $23 |
| Aesculap, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| AstraZeneca | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Dynasplint Systems Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$812
How this compares
$1,486 in reported general payments places this provider in the 80th percentile of 1,326 nurse practitioner providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 76 | $622 |
| Tizanidine Hcl | 78 | $329 |
| Methylprednisolone | 41 | $251 |
| Ondansetron Hcl | 35 | $214 |
| Meloxicam | 56 | $97 |
| Cyclobenzaprine Hcl | 14 | $57 |
| Tramadol Hcl | 19 | $37 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Leawood
- Gary GrafTopeka$726K
- Sarah FitzmauriceKansas City$247K
- Anna ShortRoeland Park$215K
- Shannon GreggTopeka$140K
- Morteza RabiiOverland Park$88K
- Constance JacobWichita$65K
- Michelle KirkHutchinson$58K
- Catherine PowellWichita$50K
- Lori RanalloWestwood$48K
- Kristyn MilburnPleasanton$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.